SynaptixBio

Oxford biotech firm secures £13.2m to develop first treatment for rare, incurable, deadly disease.

A pioneering biotech firm has secured £13.2 million to fund its mission to develop the world’s first treatment for a rare, incurable and...

281 views

British biotech firm secures FDA rare paediatric disease designation

British biotech firm secures FDA rare paediatric disease designation in bid to develop world’s first treatment for incurable, deadly disease

163 views

Children with undiagnosed conditions urged to get checked for rare, incurable and deadly disease

49 views

We were delighted to welcome Sky News to Oxfordshire in November

32 views

The powerful story of Frankie Sheridan-Hill, aged seven, featured on ITV

23 views

SynaptixBio agrees US children’s hospital deal to develop world’s first treatment for deadly disease

Biotech firm enters into a pioneering new licence agreement in bid to develop world’s first treatment for deadly disease

114 views

‘Time running out’ in teen girl’s battle with TUBB4a leukodystrophy

85 views

Thousands of patients could have rare life-threatening diseases without knowing it, experts warn

Thousands of patients could unknowingly suffer with a rare life-threatening disease, experts have warned. TUBB4a leukodystrophy - an...

3 views

Mum diagnoses daughter's rare life-threatening disease

17 views

New biotech firm launched to develop ‘revolutionary’ treatment for one of world’s rarest diseases

New biotech firm launched to develop ‘revolutionary’ new treatment for one of world’s rarest neurodegenerative diseases

63 views